MyHealtheVet to Enable Shared Decision Making Regarding Menopausal in Postmenopausal Women Veterans (MEANS)
NCT ID: NCT03109145
Last Updated: 2021-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
859 participants
INTERVENTIONAL
2014-10-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Menopause Interactive Decision Aid System
NCT00345072
Measuring Quality of Decisions About Treatment of Menopausal Symptoms
NCT01152294
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
NCT06975111
A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness
NCT00691067
Midlife Cholesterol Study
NCT00361075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
MEANS will be applied in target population consisting of postmenopausal women Veterans ages 45 to 60 who receive primary care at the Miami Veterans Affairs Healthcare System. This project will enroll women in MyHealtheVet, develop a library of menopause symptoms material for distribution, and evaluate how useful of MyHealtheVet use for educating and tracking women regarding menopause symptoms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Menopause educational secure messaging
Secure messages that provide information about menopause and treatment option for menopause symptoms.
Menopause educational secure messaging
Participants read educational material about menopause and treatment option for menopause symptoms once a week using secure messaging on a electronic patient portal.
Usual care: Control
Control group of eligible women patients between 45-60 years who do not receive the intervention at the West Palm Beach and Orlando Veterans Healthcare System. Usual care participants did not receive the educational secure messages.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Menopause educational secure messaging
Participants read educational material about menopause and treatment option for menopause symptoms once a week using secure messaging on a electronic patient portal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive primary care at the Miami Veterans Affairs Healthcare System
* Able to communicate in English
* Already or willing to register and become authenticated in the patient health portal, MyHealtheVet.
* Able to use read, understand, and respond to secure messages using patient health portal.
Exclusion Criteria
* Not willing to receive educational secure messages from patient health portal.
45 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Miami VA Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuti Dang
Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuti Dang, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Miami VA Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miami Veterans Affairs Healthcare System
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lamba AH, Muralidhar K, Jain A, Tang F, Gomez-Marin O, Levis S, Dang S. Characteristics of Women Enrolled in a Patient Portal Intervention for Menopause. Womens Health Rep (New Rochelle). 2020 Oct 26;1(1):500-510. doi: 10.1089/whr.2020.0091. eCollection 2020.
Dang S, Thavalathil B, Ruiz D, Gomez-Orozco C, Gomez-Marin O, Levis S. A Patient Portal Intervention for Menopause Knowledge and Shared Decision-Making. J Womens Health (Larchmt). 2019 Dec;28(12):1614-1622. doi: 10.1089/jwh.2018.7461. Epub 2019 Aug 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15911255
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Pfizer-MEANS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.